Back to Search
Start Over
Regulatory Dendritic Cells Restrain NK Cell IFN-γ Production through Mechanisms Involving NKp46, IL-10, and MHC Class I-Specific Inhibitory Receptors.
- Source :
-
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2015 Sep 01; Vol. 195 (5), pp. 2141-8. Date of Electronic Publication: 2015 Jul 31. - Publication Year :
- 2015
-
Abstract
- Cross-talk between mature dendritic cells (mDC) and NK cells through the cell surface receptors NKp30 and DNAM-1 leads to their reciprocal activation. However, the impact of regulatory dendritic cells (regDC) on NK cell function remains unknown. As regDC constrain the immune response in different physiological and pathological conditions, the aim of this work was to investigate the functional outcome of the interaction between regDC and NK cells and the associated underlying mechanisms. RegDC generated from monocyte-derived DC treated either with LPS and dexamethasone, vitamin D3, or vitamin D3 and dexamethasone instructed NK cells to secrete lower amounts of IFN-γ than NK cells exposed to mDC. Although regDC triggered upregulation of the activation markers CD69 and CD25 on NK cells, they did not induce upregulation of CD56 as mDC, and silenced IFN-γ secretion through mechanisms involving insufficient secretion of IL-18, but not IL-12 or IL-15 and/or induction of NK cell apoptosis. Blocking experiments demonstrated that regDC curb IFN-γ secretion by NK cells through a dominant suppressive mechanism involving IL-10, NK cell inhibitory receptors, and, unexpectedly, engagement of the activating receptor NKp46. Our findings unveil a previously unrecognized cross-talk through which regDC shape NK cell function toward an alternative activated phenotype unable to secrete IFN-γ, highlighting the plasticity of NK cells in response to tolerogenic stimuli. In addition, our findings contribute to identify a novel inhibitory role for NKp46 in the control of NK cell function, and have broad implications in the resolution of inflammatory responses and evasion of antitumor responses.<br /> (Copyright © 2015 by The American Association of Immunologists, Inc.)
- Subjects :
- Cell Communication drug effects
Cell Communication immunology
Cells, Cultured
Cholecalciferol immunology
Cholecalciferol pharmacology
Costimulatory and Inhibitory T-Cell Receptors metabolism
Dendritic Cells drug effects
Dendritic Cells metabolism
Dexamethasone immunology
Dexamethasone pharmacology
Flow Cytometry
Glucocorticoids immunology
Glucocorticoids pharmacology
Histocompatibility Antigens Class I immunology
Humans
Interferon-gamma biosynthesis
Interleukin-10 metabolism
Interleukin-12 immunology
Interleukin-12 metabolism
Interleukin-18 immunology
Interleukin-18 metabolism
Killer Cells, Natural drug effects
Killer Cells, Natural metabolism
Lipopolysaccharides immunology
Lipopolysaccharides pharmacology
Natural Cytotoxicity Triggering Receptor 1 metabolism
Receptor Cross-Talk drug effects
Receptor Cross-Talk immunology
Vitamins immunology
Vitamins pharmacology
Costimulatory and Inhibitory T-Cell Receptors immunology
Dendritic Cells immunology
Interferon-gamma immunology
Interleukin-10 immunology
Killer Cells, Natural immunology
Natural Cytotoxicity Triggering Receptor 1 immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1550-6606
- Volume :
- 195
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Journal of immunology (Baltimore, Md. : 1950)
- Publication Type :
- Academic Journal
- Accession number :
- 26232426
- Full Text :
- https://doi.org/10.4049/jimmunol.1403161